↓ Skip to main content

The Impact of Bevacizumab (Avastin) on Survival in Metastatic Solid Tumors - A Meta-Analysis and Systematic Review

Overview of attention for article published in PLOS ONE, January 2013
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (81st percentile)
  • Good Attention Score compared to outputs of the same age and source (75th percentile)

Mentioned by

policy
1 policy source
twitter
1 X user
patent
1 patent

Citations

dimensions_citation
73 Dimensions

Readers on

mendeley
51 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
The Impact of Bevacizumab (Avastin) on Survival in Metastatic Solid Tumors - A Meta-Analysis and Systematic Review
Published in
PLOS ONE, January 2013
DOI 10.1371/journal.pone.0051780
Pubmed ID
Authors

Limor Amit, Irit Ben-Aharon, Liat Vidal, Leonard Leibovici, Salomon Stemmer

Abstract

To evaluate the effect of Bevacizumab in combination with chemotherapy on overall survival of patients with metastatic solid tumors.

X Demographics

X Demographics

The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 51 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 51 100%

Demographic breakdown

Readers by professional status Count As %
Researcher 12 24%
Other 6 12%
Student > Ph. D. Student 6 12%
Student > Bachelor 5 10%
Student > Postgraduate 4 8%
Other 10 20%
Unknown 8 16%
Readers by discipline Count As %
Medicine and Dentistry 24 47%
Agricultural and Biological Sciences 4 8%
Biochemistry, Genetics and Molecular Biology 3 6%
Nursing and Health Professions 2 4%
Pharmacology, Toxicology and Pharmaceutical Science 1 2%
Other 5 10%
Unknown 12 24%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 7. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 22 December 2020.
All research outputs
#4,864,208
of 24,010,679 outputs
Outputs from PLOS ONE
#72,308
of 206,038 outputs
Outputs of similar age
#50,785
of 286,120 outputs
Outputs of similar age from PLOS ONE
#1,228
of 5,014 outputs
Altmetric has tracked 24,010,679 research outputs across all sources so far. Compared to these this one has done well and is in the 79th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 206,038 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 15.6. This one has gotten more attention than average, scoring higher than 64% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 286,120 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 81% of its contemporaries.
We're also able to compare this research output to 5,014 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 75% of its contemporaries.